Literature DB >> 15027044

Can we trust depression screening instruments in healthy 'old-old' adults?

Lea C Watson1, Carmen L Lewis, Christine E Kistler, Halle R Amick, Malaz Boustani.   

Abstract

OBJECTIVE: Despite a growing understanding of late-life depression, few studies focus on the old-old, those 75 years and over. We wished to characterize depressive symptoms and determine the accuracy of two common screening instruments for major and minor depression in a population of old-old retirees.
METHODS: Participants lived independently in one of two Continuing Care Retirement Communities and volunteered for an in-home interview about cancer screening attitudes. As part of this baseline interview, they were screened with the Geriatric Depression Scale (GDS) and the Center for Epidemiologic Studies-Depression (CES-D) scale. Those agreeing to a second interview received an evaluation using the Structured Clinical Interview for DSM-IV (SCID-IV), performed by a geriatric psychiatrist within two weeks of the initial interview.
RESULTS: In an educated and cognitively intact group of retirees averaging 80 years of age, the GDS and CES-D performed poorly using standard cutpoints in detecting both major (sensitivity 60% for both) and minor (sensitivity 33% and 50%, respectively) depression. One in five participants had significant depression as confirmed by SCID-IV evaluation. Twelve percent had major depression and 7% had minor depression. Most participants had their first episode of either after age 60.
CONCLUSIONS: Contrary to most studies evaluating the GDS and CES-D for accuracy in detecting late-life depression, these instruments at standard cutpoints performed poorly in this group of healthy older adults. The healthy old-old may require novel screening interventions to detect clinically significant depression. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15027044     DOI: 10.1002/gps.1082

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

1.  Sex Differences in the Relationship between Depressive Symptoms and Risk of Amnestic Mild Cognitive Impairment.

Authors:  Erin E Sundermann; Mindy J Katz; Richard B Lipton
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-09       Impact factor: 4.105

Review 2.  Gene-environment interactions in geriatric depression.

Authors:  Francis E Lotrich
Journal:  Psychiatr Clin North Am       Date:  2011-06

3.  Evaluating risk factors and possible mediation effects in posttraumatic depression and posttraumatic stress disorder comorbidity.

Authors:  Sydney Chiu; Justin K Niles; Mayris P Webber; Rachel Zeig-Owens; Jackson Gustave; Roy Lee; Linda Rizzotto; Kerry J Kelly; Hillel W Cohen; David J Prezant
Journal:  Public Health Rep       Date:  2011 Mar-Apr       Impact factor: 2.792

4.  Strategies for identifying and channeling patients for depression care management.

Authors:  Jennifer K Taylor; Michael Schoenbaum; Wayne J Katon; Harold A Pincus; Diane M Hogan; Jurgen Unutzer
Journal:  Am J Manag Care       Date:  2008-08       Impact factor: 2.229

5.  Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population.

Authors:  Linda G Marc; Patrick J Raue; Martha L Bruce
Journal:  Am J Geriatr Psychiatry       Date:  2008-11       Impact factor: 4.105

6.  Practical depression screening in residential care/assisted living: five methods compared with gold standard diagnoses.

Authors:  Lea C Watson; Sheryl Zimmerman; Lauren W Cohen; Rosalie Dominik
Journal:  Am J Geriatr Psychiatry       Date:  2009-07       Impact factor: 4.105

Review 7.  Assessment of late-life depression via self-report measures: a review.

Authors:  Michela Balsamo; Fedele Cataldi; Leonardo Carlucci; Caterina Padulo; Beth Fairfield
Journal:  Clin Interv Aging       Date:  2018-10-16       Impact factor: 4.458

8.  Subthreshold Depression Needs A Prime Time In Old Age Psychiatry? A Narrative Review Of Current Evidence.

Authors:  Marina Maria Biella; Marcus Kiiti Borges; Jason Strauss; Sivan Mauer; José Eduardo Martinelli; Ivan Aprahamian
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-23       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.